Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antihypertensive Drugs and COVID-19 Risk
Laura Semenzato, Jérémie Botton, Jérôme Drouin, et al.
Hypertension (2021) Vol. 77, Iss. 3, pp. 833-842
Open Access | Times Cited: 111

Showing 1-25 of 111 citing articles:

Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people
Laura Semenzato, Jérémie Botton, Jérôme Drouin, et al.
The Lancet Regional Health - Europe (2021) Vol. 8, pp. 100158-100158
Open Access | Times Cited: 215
Role of Hypertension on the Severity of COVID-19: A Review
Mei Peng, Jia He, Ying Xue, et al.
Journal of Cardiovascular Pharmacology (2021) Vol. 78, Iss. 5, pp. e648-e655
Open Access | Times Cited: 124
Crosstalk between the renin–angiotensin, complement and kallikrein–kinin systems in inflammation
Zivile Békássy, Ingrid Lopatko Fagerström, Michael Bäder, et al.
Nature reviews. Immunology (2021) Vol. 22, Iss. 7, pp. 411-428
Open Access | Times Cited: 120
Blood Pressure Control Among US Adults, 2009 to 2012 Through 2017 to 2020
Paul Muntner, Miriam A. Miles, Byron C. Jaeger, et al.
Hypertension (2022) Vol. 79, Iss. 9, pp. 1971-1980
Open Access | Times Cited: 119
COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment
Khalil El Karoui, An S. De Vriese
Kidney International (2022) Vol. 101, Iss. 5, pp. 883-894
Open Access | Times Cited: 117
Arterial hypertension – Clinical trials update 2021
Hussam Al Ghorani, Felix Götzinger, Michael Böhm, et al.
Nutrition Metabolism and Cardiovascular Diseases (2021) Vol. 32, Iss. 1, pp. 21-31
Open Access | Times Cited: 84
COVID-19 and Hypertension: The What, the Why, and the How
Shah-Abas Muhamad, Azizah Ugusman, Jaya Kumar, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 70
Efficacy of Losartan in Hospitalized Patients With COVID-19–Induced Lung Injury
Michael A. Puskarich, Nicholas E. Ingraham, Lisa H. Merck, et al.
JAMA Network Open (2022) Vol. 5, Iss. 3, pp. e222735-e222735
Open Access | Times Cited: 52
A modified self‐controlled case series method for event‐dependent exposures and high event‐related mortality, with application to COVID‐19 vaccine safety
Yonas Ghebremichael‐Weldeselassie, Marie-Joëlle Jabagi, Jérémie Botton, et al.
Statistics in Medicine (2022) Vol. 41, Iss. 10, pp. 1735-1750
Open Access | Times Cited: 50
Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19
Keiji Kuba, Tomokazu Yamaguchi, Josef Penninger
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 54
ACE2-like carboxypeptidase B38-CAP protects from SARS-CoV-2-induced lung injury
Tomokazu Yamaguchi, Midori Hoshizaki, Takafumi Minato, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 44
Prevalence, predictors, and patient-reported outcomes of long COVID in hospitalized and non-hospitalized patients from the city of São Paulo, Brazil
Daniel Tavares Malheiro, Sabrina Bernardez‐Pereira, Kauê Capellato Junqueira Parreira, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 6
IL-10 and IL-12 (P70) Levels Predict the Risk of Covid-19 Progression in Hypertensive Patients: Insights From the BRACE-CORONA Trial
Renata Moll-Bernardes, Andréa Silvestre de Sousa, Ariane Vieira Scarlatelli Macedo, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 32
Hyperactivated RAGE in Comorbidities as a Risk Factor for Severe COVID-19—The Role of RAGE-RAS Crosstalk
Sara Chiappalupi, Laura Salvadori, Rosario Donato, et al.
Biomolecules (2021) Vol. 11, Iss. 6, pp. 876-876
Open Access | Times Cited: 30
COVID-19 Vasculitis and vasculopathy-Distinct immunopathology emerging from the close juxtaposition of Type II Pneumocytes and Pulmonary Endothelial Cells
Sami Giryes, Nicola Luigi Bragazzi, Charlie Bridgewood, et al.
Seminars in Immunopathology (2022) Vol. 44, Iss. 3, pp. 375-390
Open Access | Times Cited: 22
Functional ACE2 deficiency leading to angiotensin imbalance in the pathophysiology of COVID-19
Joshua R. Cook, John C. Ausiello
Reviews in Endocrine and Metabolic Disorders (2021) Vol. 23, Iss. 2, pp. 151-170
Open Access | Times Cited: 27
Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vaccinated with mRNA-based vaccines
Jérémie Botton, Rosemary Dray‐Spira, Bérangère Baricault, et al.
Vaccine (2021) Vol. 40, Iss. 3, pp. 414-417
Open Access | Times Cited: 25
A low aldosterone/renin ratio and high soluble ACE2 associate with COVID-19 severity
Şakir Akın, Paula Schriek, Cees van Nieuwkoop, et al.
Journal of Hypertension (2021) Vol. 40, Iss. 3, pp. 606-614
Open Access | Times Cited: 25
Leveraging the Electronic Health Record to Address the COVID-19 Pandemic
Benjamin A. Satterfield, Ozan Dikilitas, Iftikhar J. Kullo
Mayo Clinic Proceedings (2021) Vol. 96, Iss. 6, pp. 1592-1608
Open Access | Times Cited: 24
Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research
Jordan Loader, Frances Taylor, Erik Lampa, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 11
Open Access | Times Cited: 19
Association of Statins for Primary Prevention of Cardiovascular Diseases With Hospitalization for COVID‐19: A Nationwide Matched Population‐Based Cohort Study
Kim Bouillon, Bérangère Baricault, Laura Semenzato, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 12
Open Access | Times Cited: 19
Effectiveness of BNT162b2, mRNA-1273, and ChAdOx1-S vaccines against severe covid-19 outcomes in a nationwide mass vaccination setting: cohort study
Kim Bouillon, Bérangère Baricault, Jérémie Botton, et al.
BMJ Medicine (2022) Vol. 1, Iss. 1, pp. e000104-e000104
Open Access | Times Cited: 19
Decreasing trends in potentially inappropriate medications in older people: a nationwide repeated cross-sectional study
Solène Drusch, Thien Le Tri, Joël Ankri, et al.
BMC Geriatrics (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 23
Immune system changes in those with hypertension when infected with SARS-CoV-2
Sheng Su, Ruirong Chen, Shaofen Zhang, et al.
Cellular Immunology (2022) Vol. 378, pp. 104562-104562
Open Access | Times Cited: 16
Which ones, when and why should renin-angiotensin system inhibitors work against COVID-19?
Mariele Montanari, Barbara Canonico, Evelyn Nordi, et al.
Advances in Biological Regulation (2021) Vol. 81, pp. 100820-100820
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top